Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: A systematic review of the literature

Psycho-Oncology

Volumn 22, Issue 4, 2013, Pages 721-736

  Rychetnik, Lucie ^a   McCaffery, Kirsten ^a   Morton, Rachael ^a   Irwig, Les ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cancer; follow up; melanoma; oncology; psychosocial; systematic review

Indexed keywords

ANXIETY; BLOOD EXAMINATION; CANCER STAGING; DATA BASE; FOLLOW UP; HUMAN; MELANOMA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT PREFERENCE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PSYCHOSOCIAL CARE; REVIEW; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; WELLBEING; WORK EXPERIENCE;

ANXIETY; CONTINUITY OF PATIENT CARE; HUMANS; MELANOMA; NEOPLASM STAGING; PATIENT COMPLIANCE; PATIENT PREFERENCE; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; SKIN NEOPLASMS; SOCIAL SUPPORT;

EID: 84876042978     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3060     Document Type: Review

References (35)

1. Giblin A, Thomas J,. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthet Surg 2007; 60: 32-40.
2. Australian Institute of Health and Welfare. Australia's Health 2010. AIHW: Canberra, 2010.
3. Balch CM, Gershenwald JE, Soong SJ, et al,. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27 (36): 6199-6206.
4. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand (Follow-up, Chapter 19). Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group: Wellington, 2008.
5. Francken AB, Bastiaannet E, Hoekstra HJ,. Follow-up in patients with localised primary cutaneous melanoma. [Review] Lancet Oncol 2005; 6 (8): 608-621.
6. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand (Psychosocial Issues in Melanoma, Chapter 14). Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group: Wellington, 2008.
7. Boyle DA,. Psychological adjustment to the melanoma experience. Semin Oncol Nurs 2003; 19 (1): 70-77.
8. Dancey A, Rayatt S, Courthold J, Roberts J,. Views of UK melanoma patients on routine follow-up care. Br J Plast Surg 2005; 58 (2): 245-250.
9. Kasparian NA, McLoone JK, Butow PN, Kasparian NA, McLoone JK, Butow PN,. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009; 145 (12): 1415-1427.
10. Baughan CA, Hall VL, Leppard BJ, Perkins PJ,. Follow-up in stage I cutaneous malignant melanoma: an audit. Clin Oncol 1993; 5 (3): 174-180.
11. Francken AB, Accortt NA, Shaw HM, et al,. Follow-up schedules after treatment for malignant melanoma. Br J Surg 2008; 95 (11): 1401-1407.
12. Turner RM, Bell KJL, Morton R, et al,. Optimizing the frequency of follow up visits for patients treated for localised primary cutaneous melanoma. J Clin Oncol 2011; 29 (35): 4641-4646.
13. Bossuyt PMM, McCaffery K,. Additional patient outcomes and pathways in evaluations of testing. Med Decis Making 2009; 29 (5): E30-38.
14. Wheeler T,. Psychological consequences of malignant melanoma: patients' experiences and preferences. Nurs Stand 2006; 21 (10): 42-46.
15. Cornish D, Holterhues C, van de Poll-Franse LV, Coebergh JW, Nijsten T,. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009; 20: 51-58.
16. Oliveria SA, Hay JL, Geller AC, Heneghan MK, McCabe MS, Halpern AC,. Melanoma survivorship: research opportunities. J Cancer Surviv 2007; 1 (1): 87-97.
17. Effective Public Health Practice Project. Quality Assessment Tool for Quantitative Studies, 2010. Available from: http://www.ephpp.ca/Tools.html. Accessed 20 May 2011.
18. Tong A, Sainsbury P, Craig J, Tong A, Sainsbury P, Craig J,. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19 (6): 349-357.
19. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH,. Presenting results and 'Summary of findings' tables-results without meta-analyses In Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0: The Cochrane Collaboration, Higgins J, Green S, (eds.), 2011.
20. Noyes J, Popay J, Pearson A, Hannes K, Booth A,. Qualitative research and Cochrane reviews. In Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2: The Cochrane Collaboration, Higgins J, Green S, (eds.), 2009.
21. Sollner W, Zingg-Schir M, Rumpold G, Fritsch P,. Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 1997; 133 (3): 316-321.
22. Sollner W, Zingg-Schir M, Rumpold G, Mairinger G, Fritsch P,. Need for supportive counselling-the professionals' versus the patients' perspective. A survey in a representative sample of 236 melanoma patients. Psychother Psychosom 1998; 67 (2): 94-104.
23. Brandberg Y, Mansson-Brahme E, Ringborg U, Sjoden PO,. Psychological reactions in patients with malignant melanoma. Eur J Cancer. 31A 1995; 2: 157-162.
24. Hormbrey E, Banwell P, Gillespie P, Budny P,. Melanoma follow-up: protocols and practice. Br J Dermatol 2000; 142 (3): 585-586.
25. Schiffner R, Schiffner-Rohe J, Landthaler M, Stolz W,. Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance. Br J Dermatol 2003; 149 (1): 79-86.
26. Kittler H, Weitzdorfer R, Pehamberger H, Wolff K, Binder M,. Compliance with follow-up and prognosis among patients with thin melanomas. Eur J Cancer 2001; 37 (12): 1504-1509.
27. Murchie P, Nicolson MC, Hannaford PC, Raja EA, Lee AJ, Campbell NC,. Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial. Br J Cancer 2010; 102 (10): 1447-1455.
28. Murchie P, Delaney EK, Campbell NC, Hannaford PC,. GP-led melanoma follow-up: views and feelings of patient recipients. Support Care Cancer 2010; 18 (2): 225-233.
29. Murchie P, Delaney EK, Campbell NC, Hannaford PC,. GP-led melanoma follow-up: the practical experience of GPs. Fam Pract 2009; 26 (4): 317-324.
30. Murchie P, Hannaford PC, Wyke S, Nicolson MC, Campbell NC,. Designing an integrated follow-up programme for people treated for cutaneous malignant melanoma: a practical application of the MRC framework for the design and evaluation of complex interventions to improve health. Fam Pract 2007; 24 (3): 283-292.
31. Qureshi AA, Brandling-Bennett HA, Wittenberg E, Chen SC, Sober AJ, Kvedar JC,. Willingness-to-pay stated preferences for telemedicine versus in-person visits in patients with a history of psoriasis or melanoma. Telemed J E-Health 2006; 12 (6): 639-643.
32. Nashan D, Kirschner F, Strittmatter G, et al,. Patients' view of melanoma follow-up. J Dtsch Dermatol Ges 2004; 2 (2): 105-110.
33. Mijnhout GS, Teule GJ, Hoekstra OS, Pijpers R, Borgstein PJ, Meijer S,. Follow-up after melanoma resection is more extensive than recommended in the practice guidelines, primarily for reassurance of the patient. Ned Tijdschr Geneeskd 1999; 143 (19): 997-1001.
34. Francken AB, Shaw HM, Accortt NA, et al,. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007; 14 (6): 1924-1933.
35. Hoekstra HJ, Francken AB,. MELFO study protocol: prospective randomized trial for the evaluation of a theoretical follow-up schedule in cutaneous melanoma patients, 2007. Available from: http://dissertations.ub.rug.nl/FILES/ faculties/medicine/2007/a.b.francken/melfo.pdf [Accessed 17 May 2011].